Natalie Dayneka

Dr. Natalie Dayneka is a Canadian clinical paediatric pharmacist based in Ottawa, Ontario. She is notable during the COVID-19 pandemic due to her role in approving COVID-19 vaccines while serving on the National Advisory Committee on Immunization (NACI).1)

Career

Dayneka has worked as a pharmacist in several locations including Churchill, Manitoba, Philadelphia, and at SickKids in Toronto, Ontario.2)

She has published research on behalf of the Department of Pharmaceutics at the State University of New York School of Pharmacy and the Philadelphia College of Pharmacy and Science.3)

Dayneka is a clinical specialist with the Pharmacy Department of the tertiary care pediatric teaching hospital Children's Hospital of Eastern Ontario (CHEO).4) She was a co-author of the online 2015 CHEO Antimicrobial Guidelines for Children which has been offered externally as a mobile application (APP) for pediatric practitioners across Canada.

She has consulted on various federal committees and was a member of the Pharmacology and Therapeutics Committee for the First Nations and Inuit Health Programs Directorate. She also served on the Canadian Paediatric Society's Drug Therapy and Hazardous Substances Committee. CPS receives funding through sponsorships by Abbott, AstraZeneca, Canadian Institutes for Health Research, Elvium Life Sciences, GlaxoSmithKline, Johnson & Johnson, Medexus Pharma, Merck, Pendopharm, Pfizer, Sanofi Genzyme, and UltraGenyx.5)

More recently, she served on the Ontario Quality Based Procedure Tonsillectomy Clinical Expert Advisory Group.6)

Canadian Society of Hospital Pharmacists

Canadian HIV/AIDS Pharmacists Network

Dayneka has served as a member, Chair and Past Chair of the Canadian HIV/AIDS Pharmacists Network (CHAP) (now called the Canadian HIV and Viral Hepatitis Pharmacists Network),14) 15) 16) where she published research sponsored by Merck.17) Additional sponsors of the network during her membership include Abbott, AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Theratechnologies, and ViiV Healthcare.18) The network itself is sponsored by the Toronto General Hospital HIV Clinic, which is funded through unrestricted grants by AbbVie, Gilead Sciences and ViiV Healthcare.19)

Public Health Agency of Canada

Dayneka is employed by the Public Health Agency of Canada's Immunization Branch as a senior advisor in Causality Assessment for COVID-19 vaccine surveillance.20) 21)

National Advisory Committee on Immunization

Dayneka formerly served on the National Advisory Committee on Immunization (NACI), including as chair of the Vaccine Safety Working Group.22)

Research

Dayneka has published research on H1N1 influenza vaccines.23)

Funding

In 1993, Dayneka received research funding from the National Institute of General Medicine Services (NIGMS) under the National Institutes of Health (NIH).24) She disclosed engaging in consulting activities for Gilead Sciences and Janssen.25) Further research was funded by AstraZeneca, Cook, and Covidien.26)

1)
National Advisory Committee on Immunization (NACI): Membership and representation. (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html
2)
Children's Healthcare Canada. (2013, September 27). Improving Adolescent Medication Adherence. YouTube. https://web.archive.org/web/20220419175950/https://www.youtube.com/watch?v=OgsPiCH27fg
3) , 24)
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993). Comparison of four basic models of indirect pharmacodynamic responses. Journal of Pharmacokinetics and Biopharmaceutics, 21(4), 457–478. https://doi.org/10.1007/bf01061691
4)
Natalie Dayneka - Clinical Specialist and.. - CHEO. ZoomInfo. Retrieved April 19, 2022, from https://web.archive.org/web/20220419191517/https://www.zoominfo.com/p/Natalie-Dayneka/87864102
5)
Canadian Paediatric Society. Thank our partners. 98th Annual Conference | Canadian Paediatric Society. Retrieved April 19, 2022, from https://archive.ph/Sq1DQ
6)
Paediatric Tonsillectomy with and without Adenoidectomy QBP Clinical Expert Advisory Group. (2015, July). Wayback Machine; Provincial Council for Maternal and Child Health. https://web.archive.org/web/20210304094328/https://www.pcmch.on.ca/wp-content/uploads/2015/07/QBP_Tonsillectomy_Membership.pdf
7)
Annual Professional Practice Conference - Awards Program. (2019, February 2). Wayback Machine; Canadian Society of Hospital Pharmacists. https://web.archive.org/web/20210812133311/https://cshp.ca/document/4143/Awards2019_Final_reduced.pdf
8)
2021 Donors to the CSHP Foundation by Giving Level. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/u6NsN
9)
2020 Donors to the CSHP Foundation by Giving Level. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/IX7Ga
10)
2019 Donors to the CSHP Foundation by Giving Level. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/Aj6wg
11)
2018 Donors to the CSHP Foundation by Giving Level. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/ofnfV
12)
2017 Donors. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/OCDBC
13)
2016 Donors. Canadian Society of Hospital Pharmacists. Retrieved April 19, 2022, from https://archive.ph/uWyb4
14)
Network. Canadian HIV/AIDS Pharmacists Network. Retrieved April 19, 2022, from https://web.archive.org/web/20220419182107/https://hivclinic.ca/chap/network.php
15)
Dayneka, N., Sheehan, N., Kelly, D., Lemire, B., Martel, D., Turcotte, I., Marquis, M.-P., Laroche, M., Therrien, R., Giguère, P., Yoong, D., Tseng, A., Robinson, L., Chan, S., Stuber, M., Hughes, C., Foisy, M., Kapler, J., Mah Ming, J., & Akagi, L. (2016). Fall 2016 Newsletter. The Canadian HIV/AIDS Pharmacists Network (CHAP). https://web.archive.org/web/20220419182634/https://hivclinic.ca/chap/downloads/newsletters/newsletter_2016_fall.pdf
16)
Hughes, C., & Meneilly, G. (2000). Annual Meeting 2000 Minutes. Canadian HIV/AIDS Pharmacists Network. https://web.archive.org/web/20220419183515/https://hivclinic.ca/chap/downloads/minutes/minutes_2000.pdf
17)
Taylor, S. A. N., Foisy, M. M., Tseng, A., Beardsall, A., Ostrop, N., Khaliq, Y., Shevchuk, Y., Chin, T., Gin, A., Dayneka, N., Slater, K., Meneilly, G., and Hughes, C. for the Canadian Collaborative HIV/AIDS Pharmacy Network. (2000). The role of the pharmacist caring for people living with HIV/AIDS: A Canadian position paper. Can J Hosp Pharm, 53(2), 92–103. https://web.archive.org/web/20220419181446/https://www.hivclinic.ca/chap/downloads/Role_of_the_pharmacist_CHAP_position_paper_CJHP00.pdf
18)
CHAP Annual Meetings. Canadian HIV and Viral Hepatitis Pharmacists Network. Retrieved April 19, 2022, from https://archive.ph/0lNW7
19)
Courage Lives Here. Immunodeficiency Clinic. Retrieved April 19, 2022, from https://web.archive.org/web/20220419182422/https://hivclinic.ca/
20)
Shared Services Canada (SSC), & Minister of Public Services and Procurement. (2021, August 26). Natalie Dayneka · Public Health Agency of Canada. OpenGovCA. https://archive.ph/DENnS
21)
Natalie Dayneka. GoC411. Retrieved April 19, 2022, from http://www.goc411.ca/en/372788/Natalie-Dayneka
22)
Dayneka, N., Jensen, C., & Hildebrand, K. (2020). Canadian Immunization Guide: “Anaphylaxis and other acute reactions following vaccination” chapter update. Canada Communicable Disease Report, 46(1112), 384–386. https://doi.org/10.14745/ccdr.v46i1112a04
23)
SchulerCHEO, J. E., King, W. J., Dayneka, N. L., Rastelli, L., Marquis, E., Chad, Z., & Hui, C. (2011). Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease. Canadian Journal of Public Health, 102(3), 196–199. https://doi.org/10.1007/bf03404895
25)
Kreutzwiser, D., Sheehan, N., Dayneka, N., Lemire, B., Wong, A., Samson, L., & Brophy, J. (2016). Therapeutic drug Monitoring Guided Raltegravir Dosing for Prevention of Vertical Transmission in a Premature Neonate Born to a Woman Living with Perinatally Acquired HIV. Antiviral Therapy, 22(6), 545–549. https://doi.org/10.3851/imp3139
26)
Stewart, P., Dayneka, N., Grenier, S., Stewart, C., Beadow, L., Joseph, G., Mack, D., & Vaillancourt, R. (2009). In Vitro Study of Esomeprazole Sachet Suspension Administered via Enteral Feeding Tubes. The Canadian Journal of Hospital Pharmacy, 62(1). https://doi.org/10.4212/cjhp.v62i1.122
Print/export